Nutritional Biomarkers for the Prediction of Response to Anti-TNF-α Therapy in Crohn's Disease: New Tools for New Approaches

• Published in: Nutrients 2024-01, Vol.16 (2), p.280
• Main Authors: Rizzello, Fernando, Saracino, Ilaria Maria, Gionchetti, Paolo, Valerii, Maria Chiara, Ricci, Chiara, Imbesi, Veronica, Filippone, Eleonora, Bellocchio, Irene, Dussias, Nikolas Konstantine, Dervieux, Thierry, Spisni, Enzo
• Format: Article
• Language: English
• Subjects: Adalimumab; Amino acids; Biological products; Biomarkers; Carbohydrates; Clinical medicine; Clinical trials; Crohn Disease - drug therapy; Crohn's disease; Diet; Dietary minerals; Food; Health aspects; Humans; Immunotherapy; Iodine; Medical research; Medicine, Experimental; Nutrients; Nutrition research; Patients; Potassium; Questionnaires; Remission (Medicine); Software; Surgery; Taurine; Tumor necrosis factor; Tumor Necrosis Factor Inhibitors; Vitamins
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu16020280

Crohn's disease (CD) is a chronic disorder of the digestive tract characterized by an uncontrolled immune-mediated inflammatory response in genetically predisposed individuals exposed to environmental risk factors. Although diet has been identified as one of the major environmental risk factors, the role of nutrients in the clinical management of CD patients has not yet been fully investigated. In this prospective observational study, fifty-four patients diagnosed with active Crohn's disease and undergoing anti-TNF-α biological therapy were enrolled and subjected to nutrient intake analysis through a daily food diary. Their nutrient intake and blood values were analyzed before and after 6 months of biological therapy. After 6 months of anti-TNF-α, four patients dropped out of the study, leaving 29 patients in clinical remission and 21 still with active disease that remained the same. The aim of this study was to identify nutrients whose intake or blood values may be associated with patients' responses to biological therapy. In the diet, patients remaining with active CD showed very similar nutrient dietary intake compared to patients achieving remission except for a trend for lower starting zinc intake, below the reference value. In the blood, instead, patients who did not respond to biological therapy showed significantly lower plasma values of iron and taurine before starting biological anti-TNF-α treatment.